<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27428232</article-id>
      <article-id pub-id-type="pmc">4956826</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000004241</article-id>
      <article-id pub-id-type="art-access-id">04241</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4100</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient</article-title>
        <subtitle>A case report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sarker</surname>
            <given-names>Azmal Kabir</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Im</surname>
            <given-names>Hyung-Jun</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paeng</surname>
            <given-names>Jin Chul</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheon</surname>
            <given-names>Gi Jeong</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
          <xref>
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>Keon Wook</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>June-Key</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Dong Soo</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zakko.</surname>
            <given-names>Saad</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Nuclear Medicine</aff>
      <aff id="aff2"><label>b</label>Fellowship of Koh Chang Soon Program, Seoul National University College of Medicine, Seoul, Korea</aff>
      <aff id="aff3"><label>c</label>National Institute of Nuclear Medicine and Allied Sciences, BAEC, BSMMU campus, Dhaka, Bangladesh</aff>
      <aff id="aff4"><label>d</label>Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University</aff>
      <aff id="aff5"><label>e</label>Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Gi Jeong Cheon, Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul, Korea (e-mail: <email>larrycheon@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>28</issue>
      <elocation-id>e4241</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">http://creativecommons.org/licenses/by-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e4241.pdf"/>
      <abstract>
        <title>Abstract</title>
        <sec sec-type="background">
          <title>Background:</title>
          <p>It has been known that plasmablastic lymphoma (PBL) is a neoplasm of immunocompromised patients occurring in soft tissue of oral cavity or in the vicinity whereas bone is an unlikely site to harbor PBL. However, its occurrence is increasingly being reported in immunocompetent individuals in either osseous or extra-oral sites. To our best knowledge, F-18 FDG PET/CT findings of PBL involving bones in an immunocompetent patient have not been reported, yet .</p>
        </sec>
        <sec>
          <title>Case summary:</title>
          <p>We report a case of PBL involving multiple bones in an immunocompetent patient. Features of different imaging modalities including F-18 Fluoro-deoxy glucose (FDG) positron emission tomography/computed tomography (PET/CT) were correlated well as findings of osteosarcoma in mandible with metastatic lesions. However, the histopathology and immunohistochemistry (IHC) of bone tissues from 2 separate biopsy sites revealed features of PBL.</p>
        </sec>
        <sec sec-type="conclusion">
          <title>Conclusion:</title>
          <p>awareness to F-18 FDG PET/CT findings of PBL involving bones in an immunocompetent patient may prevent misdiagnosis.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>case report</kwd>
        <kwd>FDG</kwd>
        <kwd>osteosarcoma</kwd>
        <kwd>PET/CT</kwd>
        <kwd>plasmablastic lymphoma</kwd>
        <kwd>skull</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Plasmablastic lymphoma (PBL), according to the World Health Organization (WHO)'s classification 2008, is characterized by diffuse proliferation of large neoplastic cells that has a morphologic resemblance to B immunoblasts with immonophenotype of plasma cells.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Immunophenotyping is the favored technique for a definite diagnosis since the first case of PBL was reported.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> There has been a number of reports of PBL that occurred predominantly in adult males who are immuno-compromised due to human immunodeficiency virus (HIV) infection or due to solid organ transplantation with a predilection for soft tissue of oral cavity or in the vicinity.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>]</sup> However, its occurrence is increasingly being reported in immuno-competent individuals and also in osseous and extra-oral sites.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R5" ref-type="bibr">5</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref>]</sup> It is observed that there is less frequent association of extraoral PBL with HIV.<sup>[<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]</sup> There are several reported cases of PBL with extraoral and osseous manifestation in addition to soft tissue PBL in immuno-competent patient .<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>]</sup> No case has yet been reported PBL arising exclusively from osseous tissue in an immuno-competent person. We report a case of PBL that was confirmed by immunohistochemistry (IHC) from the biopsy of lesions in mandible and parietal bone in an immuno-competent patient.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case report</title>
      <p>A 38-year-old male had a right-sided sub-mental swelling and a right sided mandibular mass. His management was started with the working diagnosis of primary neoplastic lesion in right mandibular ramus and condyle with metastatic tumor in right posterior temporo parietal skull bone.</p>
      <p>X-ray skull (Fig. <xref ref-type="fig" rid="F1">1</xref>) revealed round-shaped osteolytic lesion in right parieto temporal bone that was likely to be meatastatic lesion. Ultrasound of mandibular mass showed a mixed echogenic mass with minimal Doppler flow. Magnetic resonance imaging (MRI) of Paranasal sinus (PNS) (Fig. <xref ref-type="fig" rid="F2">2</xref>) showed soft tissue mass involving right mandibular ramus, angle, posterior part of body, and surrounding masticator space with T2-weighted (T2W) iso to slightly low-signal intensity, homogeneous enhancement, and sunburst periosteal reaction. MRI also revealed another soft tissue mass involving right supero-posterior parietotemporal bone. In addition, there was also diffuse infiltrative change in the subcutaneous spaces of the right neck which were more likely to be due to inflammatory change rather than tumor infiltration. A few indeterminate lymph nodes in level II on the right side were also noted.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>X-ray skull: round-shaped osteolytic lesion in the right parieto temporal bone.</p>
        </caption>
        <graphic xlink:href="medi-95-e4241-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>MRI of PNS: soft tissue mass involving right mandibular ramus, angle, posterior part of body and surrounding masticator space, soft tissue mass involving right supero-posterior parieto temporal bone, diffuse infiltrative change in the subcutaneous spaces of the right neck and a few indeterminate lymph nodes in level II on the right side. MRI = magnetic resonance imaging, PNS = paranasal sinus.</p>
        </caption>
        <graphic xlink:href="medi-95-e4241-g002"/>
      </fig>
      <p>PET/CT (Fig. <xref ref-type="fig" rid="F3">3</xref>) revealed hypermetabolic lesion on the right side of mandible with increased fluorodeoxyglucose (FDG) uptake along periosteal reaction with maximum Standard Uptake Value (SUV) of 4.0. The mandibular lesion showed a sunburst appearance on CT. The lesion in right parietal bone was hypermetabolic with a maximum SUV of 3.02. In addition, hypermetabolic lesions were also seen in right scapula and left 9th rib with maximum SUV being 2.89 and 3.07, respectively. The lesion in right parietal bone including other 2 in scapula and rib appeared osteolytic on CT images. Skeletal scintigraphy (Fig. <xref ref-type="fig" rid="F4">4</xref>) showed increased Tc-99m-methyl diphosphonate (MDP) uptake in the mandible, right parietal bone, right scapula, and left 9th rib.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>F-18 FDG PET/CT: hypermetabolic lesion on the right side of mandible, with sunburst appearance and increased FDG uptake along the periosteal reaction. Hypermetabolic lesions in the right parietal bone and right scapula. FDG = fluorodeoxyglucose, PET/CT = positron emission tomography/computed tomography.</p>
        </caption>
        <graphic xlink:href="medi-95-e4241-g003"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Tc-99m-MDP bone scan: increased tracer uptake in the mandible, right parietal bone, right scapula, and left 9th rib. MDP = methyl diphosphonate.</p>
        </caption>
        <graphic xlink:href="medi-95-e4241-g004"/>
      </fig>
      <p>Based on the imaging findings osteosarcoma of mandible with multiple metastases in parietal bone, scapula and rib were the most likely differential diagnosis. Biopsy specimen from mandible and parietal bone lesions were taken for histopathological examination. The histopathology and IHC features of both tumors were compatible with plasmablastic lymphoma; HIV serology in the patient was negative.</p>
      <p>In situ hybridization of the tumor cells revealed most of the cells to be positive for Epstein Burr virus. Human herpes virus (HHV)-8 latency-associated nuclear antigen (LANA 1) was found negative. IHC of the tumor cell revealed their positivity for Cluster of differentiation (CD) 38, CD138 and CD79&#x3B1;. Ki67 antigen was also positive in 20% tumor cells. The tumor cells were found to be negative for CD45, CD56, and CD20. These features were compatible with the WHO criteria 2008 for PBL.</p>
      <p>Patient was then treated with chemotherapy in the protocol of non-Hodgkin's lymphoma for the treatment of PBL.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Materials and methods</title>
      <p>Approval from institutional review board of Seoul National University Hospital was obtained.</p>
    </sec>
    <sec>
      <label>4</label>
      <title>Discussion</title>
      <p>In this current case, an initial differential diagnosis of osteosarcoma was made based on hybrid imaging. The reason for this was high FDG uptake on PET combined with classic feature of osteosarcoma, sunburst appearance,<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> in mandible. Patient's age and site of lesion were also compatible with the diagnosis. The immuno-competent state of the person prevented the clinical minds to think about PBL. Also compatible with the existing knowledge of tumor metabolism, osteosarcoma like most other malignancies demonstrates increased FDG uptake on PET images.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> Osteosarcoma and other malignant bone lesions tend to have SUV of &gt;2.<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> Some recent case series reports SUV of osteosarcoma ranging from 3.15 to 16.5.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Remarkable FDG uptake is reported in osteolytic bone metastases<sup>[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>]</sup> which is compatible with the fact that lesions in parietal bone, scapula, and rib appeared osteolytic on CT images while demonstrating increase FDG uptake on PET. However, there are reports of bone metastases from osteosarcoma that displayed low uptake of FDG on PET scan<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> or was false negative.<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup></p>
      <p>In the current case, all 4 bone lesions were hypermetabolic with maximum SUV between 3 and 4. There are few reported cases of soft tissue PBL with hypermetabolic activity on PET images.<sup>[<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>]</sup> Cazaentre et al<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> reports a case of soft tissue PBL showing no abnormal FDG uptake but associated hypermetabolism in retroperitoneal lymph node with SUV of 7.5.</p>
      <p>CT images of the current case showed that among the bone lesions the 1 in mandible was osteoblastic whereas the other 3 were osteolytic. In the reported cases of PBL either the lesions themselves have osteolytic appearance on CT scan<sup>[<xref rid="R21" ref-type="bibr">21</xref>&#x2013;<xref rid="R23" ref-type="bibr">23</xref>]</sup> or there was CT evidence of osteolysis adjacent to soft tissue lesions.<sup>[<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R24" ref-type="bibr">24</xref>&#x2013;<xref rid="R26" ref-type="bibr">26</xref>]</sup></p>
      <p>Though there is a report of osteolytic appearance of PBL on bone scan,<sup>[22]</sup> in this current case, concordant with the FDG uptake on PET images, bone scan demonstrated increased MDP uptake in all 4 bone lesions.</p>
    </sec>
    <sec>
      <label>5</label>
      <title>Conclusion</title>
      <p>The present case reports F-18 FDG PET/CT findings of a case of PBL arising from bone in an immunocompetent patient. Although the definite diagnosis of PBL is reliant on IHC, awareness to possible diverse finding on PET/CT images can prevent misdiagnosis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: CD = cluster of differentiation, FDG = fluorodeoxyglucose, HHV = human herpes virus, HIV = human immunodeficiency virus, IHC = immunohistochemistry, Ki 67 = antigen Ki 67, a marker of proliferation, LANA 1 = latency-associated nuclear antigen, MDP = methyl diphosphonate, MRI = magnetic resonance imaging, PBL = plasmablastic lymphoma, PET/CT = positron emission tomography/computed tomography, PNS = paranasal sinus, SUV = standard uptake value, T2W = T2 weighted, WHO = World Health Organization.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Swerdlow</surname><given-names>SHCE</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Jaffe</surname><given-names>ES</given-names></name><name><surname>Pileri</surname><given-names>SA</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name><name><surname>Thiele</surname><given-names>J</given-names></name><name><surname>Vardiman</surname><given-names>JW</given-names></name></person-group>
<article-title>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues</article-title>. <edition>4TH edn.</edition><publisher-loc>Lyon, France</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2008</year>
<fpage>256</fpage>&#x2013;<lpage>257</lpage>.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delecluse</surname><given-names>HJ</given-names></name><name><surname>Anagnostopoulos</surname><given-names>I</given-names></name><name><surname>Dallenbach</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection</article-title>. <source><italic>Blood</italic></source>
<year>1997</year>; <volume>89</volume>:<fpage>1413</fpage>&#x2013;<lpage>1420</lpage>.<pub-id pub-id-type="pmid">9028965</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafaniello Raviele</surname><given-names>P</given-names></name><name><surname>Pruneri</surname><given-names>G</given-names></name><name><surname>Maiorano</surname><given-names>E</given-names></name></person-group>
<article-title>Plasmablastic lymphoma: a review</article-title>. <source><italic>Oral Dis</italic></source>
<year>2009</year>; <volume>15</volume>:<fpage>38</fpage>&#x2013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">18939960</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>JJ</given-names></name><name><surname>Reagan</surname><given-names>JL</given-names></name></person-group>
<article-title>Plasmablastic lymphoma: a systematic review</article-title>. <source><italic>Scientific World J</italic></source>
<year>2011</year>; <volume>11</volume>:<fpage>687</fpage>&#x2013;<lpage>696</lpage>.</mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>YA</given-names></name><name><surname>Kim</surname><given-names>WY</given-names></name><etal/></person-group>
<article-title>Human immunodeficiency virus-negative plasmablastic lymphoma in Korea</article-title>. <source><italic>Leuk Lymphoma</italic></source>
<year>2009</year>; <volume>50</volume>:<fpage>582</fpage>&#x2013;<lpage>587</lpage>.<pub-id pub-id-type="pmid">19373656</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraceni</surname><given-names>C</given-names></name><name><surname>Agostino</surname><given-names>N</given-names></name><name><surname>Cornfield</surname><given-names>DB</given-names></name><etal/></person-group>
<article-title>Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review</article-title>. <source><italic>Springerplus</italic></source>
<year>2013</year>; <volume>2</volume>:<fpage>142</fpage>.<pub-id pub-id-type="pmid">23667804</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colomo</surname><given-names>L</given-names></name><name><surname>Loong</surname><given-names>F</given-names></name><name><surname>Rives</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities</article-title>. <source><italic>Am J Surg Pathol</italic></source>
<year>2004</year>; <volume>28</volume>:<fpage>736</fpage>&#x2013;<lpage>747</lpage>.<pub-id pub-id-type="pmid">15166665</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teruya-Feldstein</surname><given-names>J</given-names></name><name><surname>Chiao</surname><given-names>E</given-names></name><name><surname>Filippa</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients</article-title>. <source><italic>Ann Oncol</italic></source>
<year>2004</year>; <volume>15</volume>:<fpage>1673</fpage>&#x2013;<lpage>1679</lpage>.<pub-id pub-id-type="pmid">15520070</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansra</surname><given-names>D</given-names></name><name><surname>Montague</surname><given-names>N</given-names></name><name><surname>Stefanovic</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics</article-title>. <source><italic>Am J Clin Pathol</italic></source>
<year>2010</year>; <volume>134</volume>:<fpage>710</fpage>&#x2013;<lpage>719</lpage>.<pub-id pub-id-type="pmid">20959653</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorwal</surname><given-names>P</given-names></name><name><surname>Sachdev</surname><given-names>R</given-names></name><name><surname>Mishra</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Extraoral plasmablastic lymphoma detected using ascitic fluid cytology and flow cytometry: a case report with a review of the literature</article-title>. <source><italic>Acta Cytologica</italic></source>
<year>2014</year>; <volume>58</volume>:<fpage>309</fpage>&#x2013;<lpage>317</lpage>.<pub-id pub-id-type="pmid">24685599</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Baert</surname><given-names>ALKM</given-names></name></person-group>
<article-title>Medical Radiology Diagnostic Imaging.</article-title>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2009</year>
<fpage>278</fpage>.</mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoh</surname><given-names>CK</given-names></name><name><surname>Hawkins</surname><given-names>RA</given-names></name><name><surname>Glaspy</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-<sc>D</sc>-glucose</article-title>. <source><italic>J Comput Assisted Tomogr</italic></source>
<year>1993</year>; <volume>17</volume>:<fpage>582</fpage>&#x2013;<lpage>589</lpage>.</mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Endo</surname><given-names>K</given-names></name></person-group>
<article-title>Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study</article-title>. <source><italic>J Biomed Biotechnol</italic></source>
<year>2011</year>; <volume>2011</volume>:<fpage>807929</fpage>.<pub-id pub-id-type="pmid">21738405</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma</article-title>. <source><italic>Eur J Nucl Med Mol Imaging</italic></source>
<year>2012</year>; <volume>39</volume>:<fpage>39</fpage>&#x2013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">21953008</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakai</surname><given-names>T</given-names></name><name><surname>Okuyama</surname><given-names>C</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer</article-title>. <source><italic>Eur J Nucl Med Mol Imaging</italic></source>
<year>2005</year>; <volume>32</volume>:<fpage>1253</fpage>&#x2013;<lpage>1258</lpage>.<pub-id pub-id-type="pmid">16133397</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>HL</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>XM</given-names></name><etal/></person-group>
<article-title>Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy</article-title>. <source><italic>Eur Rad</italic></source>
<year>2011</year>; <volume>21</volume>:<fpage>2604</fpage>&#x2013;<lpage>2617</lpage>.</mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzius</surname><given-names>C</given-names></name><name><surname>Sciuk</surname><given-names>J</given-names></name><name><surname>Daldrup-Link</surname><given-names>HE</given-names></name><etal/></person-group>
<article-title>FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy</article-title>. <source><italic>Eur J Nucl Med</italic></source>
<year>2000</year>; <volume>27</volume>:<fpage>1305</fpage>&#x2013;<lpage>1311</lpage>.<pub-id pub-id-type="pmid">11007511</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shreve</surname><given-names>PD</given-names></name><name><surname>Grossman</surname><given-names>HB</given-names></name><name><surname>Gross</surname><given-names>MD</given-names></name><etal/></person-group>
<article-title>Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-<sc>D</sc>-glucose</article-title>. <source><italic>Radiology</italic></source>
<year>1996</year>; <volume>199</volume>:<fpage>751</fpage>&#x2013;<lpage>756</lpage>.<pub-id pub-id-type="pmid">8638000</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>JM</given-names></name><name><surname>Subramaniam</surname><given-names>RM</given-names></name><name><surname>Surasi</surname><given-names>DS</given-names></name><etal/></person-group>
<article-title>FDG PET/CT in patients with HIV</article-title>. <source><italic>Am J Roentgenol</italic></source>
<year>2011</year>; <volume>197</volume>:<fpage>284</fpage>&#x2013;<lpage>294</lpage>.<pub-id pub-id-type="pmid">21785073</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treglia</surname><given-names>G</given-names></name><name><surname>Paone</surname><given-names>G</given-names></name><name><surname>Stathis</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>An unusual case of plasmablastic lymphoma presenting as paravertebral mass evaluated by (18) F-FDG PET/CT</article-title>. <source><italic>Eur J Nucl Med Mol Imaging</italic></source>
<year>2014</year>; <volume>48</volume>:<fpage>89</fpage>&#x2013;<lpage>90</lpage>.</mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazaentre</surname><given-names>T</given-names></name><name><surname>Sanhes</surname><given-names>L</given-names></name><name><surname>Laurent</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Interesting image. Assessment of plasmablastic lymphoma by F-18 FDG PET/CT: case report</article-title>. <source><italic>Clin Nucl Med</italic></source>
<year>2010</year>; <volume>35</volume>:<fpage>882</fpage>&#x2013;<lpage>883</lpage>.<pub-id pub-id-type="pmid">20940549</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenabi</surname><given-names>A</given-names></name><name><surname>Mooraki</surname><given-names>A</given-names></name><name><surname>Jabbari</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder</article-title>. <source><italic>Iran J Kidney Dis</italic></source>
<year>2012</year>; <volume>6</volume>:<fpage>380</fpage>&#x2013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">22976265</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>SK</given-names></name><name><surname>Bera</surname><given-names>H</given-names></name><name><surname>Biswas</surname><given-names>PK</given-names></name><etal/></person-group>
<article-title>High-grade plasmablastic neoplasm of humerus in an HIV-negative patient, which was indeterminate between plasmablastic lymphoma and plasmablastic myeloma</article-title>. <source><italic>J Cancer Res Ther</italic></source>
<year>2011</year>; <volume>7</volume>:<fpage>214</fpage>&#x2013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">21768719</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degnan</surname><given-names>AJ</given-names></name><name><surname>Levy</surname><given-names>LM</given-names></name></person-group>
<article-title>Orbital plasmablastic lymphoma with remission following chemotherapy</article-title>. <source><italic>J Radiol Case Rep</italic></source>
<year>2011</year>; <volume>5</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22470775</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheper</surname><given-names>MA</given-names></name><name><surname>Nikitakis</surname><given-names>NG</given-names></name><name><surname>Fernandes</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature</article-title>. <source><italic>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</italic></source>
<year>2005</year>; <volume>100</volume>:<fpage>198</fpage>&#x2013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">16037778</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogia</surname><given-names>A</given-names></name><name><surname>Bakhshi</surname><given-names>S</given-names></name></person-group>
<article-title>Plasmablastic lymphoma of oral cavity in a HIV-negative child</article-title>. <source><italic>Pediatr Blood Cancer</italic></source>
<year>2010</year>; <volume>55</volume>:<fpage>390</fpage>&#x2013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">20582963</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
